We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 256 results
  1. Therapeutic Innovations Against Opioid Tolerance and Addiction

    Purpose of Review

    Opioids have a long history of use for relief of pain dating back thousands of years. Opium derived from the poppy plant is one of...

    M. Berk Basaran, Raviye Ozen Koca, Z. Isik Solak Gormus in Current Behavioral Neuroscience Reports
    Article 02 May 2024
  2. Genetic mouse models in opioid research: current status and future directions

    Synthetic and semi-synthetic opioids are prescribed for the management of severe pain conditions, but their long-term use is often leading to...

    Monserrat Avila-Zozaya, Venetia Zachariou in Journal of Neural Transmission
    Article 04 March 2024
  3. G protein-biased LPAR1 agonism of prototypic antidepressants: Implication in the identification of novel therapeutic target for depression

    Prototypic antidepressants, such as tricyclic/tetracyclic antidepressants (TCAs), have multiple pharmacological properties and have been considered...

    Naoto Kajitani, Mami Okada-Tsuchioka, ... Minoru Takebayashi in Neuropsychopharmacology
    Article Open access 06 September 2023
  4. Recent Advances in Peripheral Opioid Receptor Therapeutics

    Purpose of Review

    Although opioids are excellent analgesics, they are associated with severe short- and long-term side effects that are especially...

    Raghav Seth, Sumanth S. Kuppalli, ... Amitabh Gulati in Current Pain and Headache Reports
    Article 10 May 2021
  5. Pharmacological and genetic manipulations at the µ-opioid receptor reveal arrestin-3 engagement limits analgesic tolerance and does not exacerbate respiratory depression in mice

    Opioid drugs are widely used analgesics that activate the G protein-coupled µ-opioid receptor, whose endogenous neuropeptide agonists, endorphins and...

    Li He, Sarah W. Gooding, ... Jennifer L. Whistler in Neuropsychopharmacology
    Article Open access 13 July 2021
  6. The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder

    Although expanding the availability of buprenorphine—a first-line pharmacotherapy for opioid-use disorder (OUD)—has increased the capacity of...

    Joao P. De Aquino, Suprit Parida, Mehmet Sofuoglu in Clinical Drug Investigation
    Article 05 April 2021
  7. G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery

    G protein-coupled receptors (GPCRs), the largest family of human membrane proteins and an important class of drug targets, play a role in maintaining...

    Mingyang Zhang, Ting Chen, ... Shaoyong Lu in Signal Transduction and Targeted Therapy
    Article Open access 10 April 2024
  8. A Large-Scale Observational Study on the Temporal Trends and Risk Factors of Opioid Overdose: Real-World Evidence for Better Opioids

    Background

    The USA is in the midst of an opioid overdose epidemic. To address the epidemic, we conducted a large-scale population study on opioid...

    Jianyuan Deng, Wei Hou, ... Fusheng Wang in Drugs - Real World Outcomes
    Article Open access 26 May 2021
  9. Essential role of P-glycoprotein in the mechanism of action of oliceridine

    Mu opioid receptor (MOR) agonists comprise the most effective analgesics, but their therapeutic utility is limited by adverse effects. One approach...

    Emilya Ventriglia, Arianna Rizzo, ... Michael Michaelides in Neuropsychopharmacology
    Article 25 November 2022
  10. Current and Future Therapeutic Options in Pain Management: Multi-mechanistic Opioids Involving Both MOR and NOP Receptor Activation

    Opioids are widely used in chronic pain management, despite major concerns about their risk of adverse events, particularly abuse, misuse, and...

    Flaminia Coluzzi, Laura Rullo, ... Patrizia Romualdi in CNS Drugs
    Article Open access 26 May 2022
  11. Nociceptin Receptor-Related Agonists as Safe and Non-addictive Analgesics

    As clinical use of currently available opioid analgesics is often impeded by dose-limiting adverse effects, such as abuse liability and respiratory...

    Hui** Ding, Norikazu Kiguchi, ... Mei-Chuan Ko in Drugs
    Article 20 May 2023
  12. Orthosteric ligand selectivity and allosteric probe dependence at Hydroxycarboxylic acid receptor HCAR2

    Hydroxycarboxylic acid receptor 2 (HCAR2), a member of Class A G-protein-coupled receptor (GPCR) family, plays a pivotal role in anti-lipolytic and...

    Lin Cheng, Suyue Sun, ... Wei Yan in Signal Transduction and Targeted Therapy
    Article Open access 25 September 2023
  13. Transcriptomic profiling of reward and sensory brain areas in perinatal fentanyl exposed juvenile mice

    Use of the synthetic opioid fentanyl increased ~300% in the last decade, including among women of reproductive ages. Adverse neonatal outcomes and...

    Jimmy Olusakin, Gautam Kumar, ... Mary Kay Lobo in Neuropsychopharmacology
    Article 03 July 2023
  14. Heroin and its metabolites: relevance to heroin use disorder

    Heroin is an opioid agonist commonly abused for its rewarding effects. Since its synthesis at the end of the nineteenth century, its popularity as a...

    Michele Stanislaw Milella, Ginevra D’Ottavio, ... Aldo Badiani in Translational Psychiatry
    Article Open access 08 April 2023
  15. Acupuncture/Electroacupuncture as an Alternative in Current Opioid Crisis

    Opioid drugs are the first line of defense in severe pain but the adverse effects associated with opioids are considered as a serious issue...

    Usman Ali, Evhy Apryani, ... Yong-xiang Wang in Chinese Journal of Integrative Medicine
    Article 15 October 2019
  16. Effectiveness of interventions for prevention of common infections in people who use opioids: a protocol for a systematic review of systematic reviews

    Background

    The North American opioid crisis is driven by opioid-related mortality and morbidity, including opioid use-associated infections (OUAIs),...

    Irina Kudrina, Svetlana Puzhko, ... Mark J. Eisenberg in Systematic Reviews
    Article Open access 15 November 2021
  17. G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders

    Neuropsychiatric disorders are multifactorial disorders with diverse aetiological factors. Identifying treatment targets is challenging because the...

    Thian-Sze Wong, Guangzhi Li, ... Yang Du in Signal Transduction and Targeted Therapy
    Article Open access 03 May 2023
  18. A Brief Review on the Novel Therapies for Painful Diabetic Neuropathy

    Purpose of Review

    Almost half of people diagnosed with diabetes mellitus will develop painful diabetic neuropathy (PDN), a condition greatly impacting...

    Jade I. Basem, Fatoumata N. Bah, Neel D. Mehta in Current Pain and Headache Reports
    Article 01 July 2023
  19. Untangling the complexity of opioid receptor function

    Mu opioid receptor agonists are among the most powerful analgesic medications but also among the most addictive. The current opioid crisis has...

    Rita J. Valentino, Nora D. Volkow in Neuropsychopharmacology
    Article Open access 24 September 2018
Did you find what you were looking for? Share feedback.